Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The proportion of Americans who report having used or knowing someone who has used a GLP-1 in the past three months has consistently risen in Axios/Ipsos polling since 2023
Drucker, 2022
Wegovy has been approved for weight loss, along with diet and exercise, for individuals aged 12 years and above with obesity or some overweight adults with weight-related medical problems
:max_bytes(150000):strip_icc()/VWH-GettyImages-2196287905-42e440cc5f714dfb8793161a905904d9.jpg)
References Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical Programme, 16 September 2025, Novo Nordisk, DAscanio AM, Mullally JA, Frishman WH
US$ 28.51
US$ 28.59
US$ 25.11
